Spreading the Word About Thrombosis
After fracturing her ankle and getting a cast, South African athlete Marie-Victoire Cumming began feeling extreme discomfort in her leg. What she didn't know was that she had a potentially life-threatening condition called deep vein thrombosis.
Blood Clot Risks Found for Hospitalized Children
Venous thromboembolism (VTE) is rare in children, which often causes it to be overlooked, leading to delays in treatment that can sometimes be deadly.
Stop Blood Clots, Prevent Future Strokes
Ischemic stroke is the third leading cause of death in the United States. Preventing future ischemic strokes means preventing more blood clots from forming.
How You Get Pregnant Can Signal Health Risks
In vitro fertilization can help infertile women get pregnant. But getting pregnant using in vitro may also put the pregnant mom at risk for health problems.
Heart Diagnostic Test Recalled
A testing system commonly used to diagnose heart problems and other medical conditions has been recalled by the U.S. Food and Drug Administration.
Nano Clot-Buster Targets Blockage
Clot-busting drug tissue plasminogen activator ( tPA ) is the only approved treatment for dissolving blood clots common during stroke, heart attacks or pulmonary embolisms.
FDA Delays Blood Thinner Eliquis Again
United States Food and Drug Administration officials today delayed approval of Eliquis ( apixaban ) to prevent stroke or systemic embolism in patients with a common heart arrhythmia for the second time.
FDA Rejects Rivaroxaban for ACS
Following a close vote, a U.S. Food and Drug Administration panel has declined to recommend r ivaroxaban ( Xarelto ) to treat acute coronary syndrome.
Risk High During Temporary Anticoagulant Halts
Patients with certain types of atrial fibrillation, a common heart arrhythmia, are at a high risk of stroke and blood clots if they temporarily stop their blood thinning medication before surgery or permanently because of side effects.
Apixaban Fails to Reduce Blood Clots
An experimental drug designed to aid severely ill patients after hospitalization is not more effective than standard treatments for reducing the risk of blood clots, a study has confirmed.